HU Weiwei  

  • Associate Chief Physician, Graduate Supervisor
  • Department: Endocrinology and Metabolism
  • Research Area: Internal medicine
  • Research Interests: Pathogenesis of osteoporosis and metabolic bone diseases
  • Contact: huweiwei1980@163.com
  • Doctor, Osteoporosis and Bone Disease, Shanghai Sixth People's Hospital, 2004
  • MD from Shanghai Jiao Tong University School of Medicine, 2019
  • Master's degree from Shanghai Jiao Tong University School of Medicine, 2010
  • Associate Chief Physician, Department of Osteoporosis and Bone Diseases, Shanghai Sixth People's Hospital
  • Member, Osteoporosis Prevention and Rehabilitation Committee, Chinese Association of Rehabilitation Medicine
  1. Chen X, Shen, L, Gao C, Weng R, Fan Y, Xu S, Zhang Z, Hu W. Vitamin D status and its associations with bone mineral density, bone turnover markers, and parathyroid hormone in Chinese postmenopausal women with osteopenia and osteoporosis. Front Nutr. 2024;10:1307896. 
  2. Xu Y, Shen L, Liu L, Zhang Z, Hu W. Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study. Front Endocrinol (Lausanne). 2022 Jul 8;13:843912.  
  3. Hu W, He J, Qi L, Wang C, Yue H, Gu J, Zhang H, Wang Y, Zhang Z. Association of HIVEP3 Gene and Lnc RNA with Femoral Neck Bone Mineral Content and Hip Geometry by Genome-Wide Association Analysis in Chinese People. Int J Endocrinol. 2020 Oct 13; doi: 10.1155/2020/6929073.
  • 01/01/2022-12/31/2025
    National Natural Science Foundation of China, ¥55.0000, 82170895
    Study on the molecular mechanism of Osteopetrosis with EphA2 gene mutation
    Role: Principal Investigator